Posted on: October 01, 2014
Northside Hospital Healthcare System is leading the state of Georgia by offering Inspire® treatment therapy for people suffering from Obstructive Sleep Apnea (OSA). The first surgery in Georgia was performed in 2011 by Dr. Sam Mickelson from Advanced Ear Nose & Throat Associates, on staff at Northside Hospital and lead investigator for the Inspire clinical trial in Georgia.
Inspire therapy utilizes first-of-its-kind technology—a small, fully implanted system that has been clinically proven to significantly reduce sleep apnea events and significantly improve quality of life measures.
OSA affects an estimated 18 million Americans and occurs when the tongue and other soft tissues relax during sleep and obstruct the airway. This causes recurrent awakening and leads to daytime sleepiness or fatigue and increased risk of heart attack, stroke, weight gain, and high blood pressure.
Inspire therapy senses breathing patterns and delivers mild stimulation to key airway muscles, which keeps the airway open during sleep. It is a promising new treatment option for people that are not tolerating or receiving consistent benefits from continuous positive airway pressure (CPAP).
“This is exciting news for the hundreds of patients currently suffering from moderate or severe sleep apnea that cannot take advantage of traditional methods to control their condition,” said Dr. Sam Mickelson. “A good night’s sleep is important to maintaining overall health and this procedure opens doors for many people that otherwise have not had a full night of rest in years.”
Inspire therapy is a clinically proven solution. Results from the STAR trial, a clinical study conducted at 22 leading medical centers in the United States and Europe, were recently published in the New England Journal of Medicine. STAR trial results showed that the therapy reduced apnea events by 68% and significantly improved key quality of life measures.
Read more about Northside Hospital's sleep services.
Filed under: Latest News & Technology,